 |  | 

Vitamin D and breast cancer.
Christakos S
Department of Biochemistry and Molecular Biology, University of Medicine and
Dentistry of New Jersey, New Jersey Medical School, Newark, USA.
1. 1,25-Dihydroxyvitamin D3, the biologically active form of vitamin D, in
addition to regulating calcium homeostasis, also has antiproliferative and
prodifferentiating effects. 2. Most studies concerning the therapeutic
potential of analogs of 1,25(OH)2D3, which are antiproliferative and
prodifferentiating but do not cause hypercalcemia, have been done using
leukemic cells. 3. Recent evidence from both in vivo and in vitro studies has
indicated that 1,25(OH)2D3 or analogs of 1,25(OH)2D3 can inhibit the growth
of breast cancer cells, thus suggesting the therapeutic potential of analogs
of 1,25(OH)2D3 in the treatment of breast cancer.
|
 |  |  | 
 Reuters Health 10/05/01
British J of Cancer

|  |  |  | 
 JNCI, 9/02

|  |  |  |  | 
 Abstract #C141
Frontiers in Cancer Prevention Res, 2003

|  |  |  | 
 Cancer Causes & Control, 3/04

|  |  |  |  | 
 Cancer Epid, Biomarkers & Prevention,
9/04

|  |  |  | 
 AACR, 2006

|  |  |  |  | 
 Abstract 6075
San Antonio Breast Cancer Symposium

|  |
Remember we are NOT Doctors and have NO medical training.
This site is like an Encylopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM. |
|